Delivery Order SPE2DB22D2214-SPE2DB25FS5VG
- Not listed
- The Defense Logistics Agency awarded a $20,268.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 21, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,938.85 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count units) with a completion date of July 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a continuation order under AmerisourceBergen's existing federal contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where the vendor maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,588.96 to AmerisourceBergen Drug Corp for the supply of Azithromycin 250 mg tablets (30-count packages) with an ultimate completion date of July 21, 2025. This competitive award, issued on July 18, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.88 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Azithromycin 250 mg tablets (packaged as 6-unit strips). This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.23, is for the delivery of azithromycin 250mg tablets. The contract has a period of performance through February 19, 2025 and is a Firm Fixed Price contract type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This is a $2,118.88 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,562,265,700 units of Azithromycin 500 mg tablets, with a completion date of September 22, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of 4,567,198,344 units of Azithromycin 250 mg tablets, a pharmaceutical product used to treat various bacterial infections. The contract has a ceiling value of $2,371.38 and a completion date of February 7, 2025. This appears to be a delivery order contract, with a firm fixed price...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Azithromycin 500 mg tablets, a common antibiotic medication, with a ceiling value of $1,210.37 and a completion date of July 3, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a $3,209 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 4561666465, which is identified as Azithromycin 500 mg tablets in 30-count packages. This firm fixed price order is being carried out under DLA's pharmaceutical products program, with performance taking place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 1st to August 2nd, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $2,982 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 500 mg azithromycin tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 30 tablets of the antibiotic to a facility in Conshohocken, Pennsylvania by July 25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite-delivery/indefinite-quantity...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5VGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Azithromycin 500 mg tablets in a quantity of 30 units, with a ceiling value of $2,615.32. This contract utilizes a firm fixed price structure and represents a non-set-aside competitive award. The delivery order is scheduled for ultimate completion by July 21, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies medications and medical supplies to support military healthcare systems and other government agencies. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to fulfill diverse federal medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/18/25 |